Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- 9 May 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 26 (12), 1819-1830
- https://doi.org/10.1093/ibd/izaa087
Abstract
Vitamin D deficiency has been implicated in the pathogenesis of inflammatory bowel disease. Emerging literature suggests that optimization of vitamin D levels may be associated with improvements in disease activity and quality of life. We conducted a meta-analysis exploring the effect of vitamin D on serum 25-hydroxyvitamin D (s-25[OH]D) levels, clinical improvement, and biomarkers. MEDLINE, EMBASE, the Cochrane Library, and sources for grey literature were searched from inception until September 2019. The primary outcome was s-25(OH)D mean differences. Heterogeneity was assessed using the χ 2 test and the I2 statistic. Review Manager software v. 5.3 was used. Twelve randomized controlled trials (n = 611) and 4 observational studies (n = 359) were included in the meta-analysis. On average, in the randomized controlled trials, vitamin D supplementation increased s-25(OH)D levels by 15.50 ng/mL (95% confidence interval [CI], 11.08-19.92, P ≤ 0.00001, I2 = 90%) and in observational studies they increased by 18.39 ng/mL (95% CI, 8.91-27.88, P = 0.0001, I2 = 82%). Subgroup analyses between vitamin D and placebo groups revealed that vitamin D increased s-25(OH)D by 14.85 ng/mL (95% CI, 9.96-19.73, P ≤ 0.00001, I2 = 90%) and when high doses of vitamin D were compared with low doses, high doses increased s-25(OH)D by 18.27 ng/mL (95% CI, 5.44-31.10, P = 0.005, I2 = 90%). The Harvey Bradshaw Index improved by –1.47 points (95% CI, –2.47 to –0.47, P = 0.004, I2 = 0%) and the high-sensitivity C-reactive protein decreased by –1.58 mg/L (95% CI, –2.95 to –0.21, P = 0.02, I2 = 0%). Vitamin D supplementation in patients with IBD and vitamin D deficiency is effective at correcting vitamin D levels and is associated with improvement in clinical and biochemical disease activity scores.Keywords
This publication has 53 references indexed in Scilit:
- Practical Medical Management of Crohn’s DiseaseISRN Gastroenterology, 2013
- Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn's PatientsClinical and Translational Gastroenterology, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Vitamin D Deficiency in Patients With Inflammatory Bowel DiseaseJournal of Parenteral and Enteral Nutrition, 2011
- Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL‐6 production and proliferationAlimentary Pharmacology & Therapeutics, 2010
- Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2010
- Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunityNature Clinical Practice Endocrinology & Metabolism, 2008
- Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitisGut, 2005
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- A simple clinical colitis activity indexGut, 1998